Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.

MLA

Feizi, Sholeh, et al. “Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium Abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.” ACS Applied Materials & Interfaces, vol. 16, no. 51, Dec. 2024, pp. 70274–83. EBSCOhost, https://doi.org/10.1021/acsami.4c15843.

APA

Feizi, S., Awad, M., Ramezanpour, M., Cooksley, C., Murphy, W., Prestidge, C. A., Psaltis, A. J., Wormald, P.-J., Barry, S., & Vreugde, S. (2024). Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles. ACS Applied Materials & Interfaces, 16(51), 70274–70283. https://doi.org/10.1021/acsami.4c15843

Chicago

Feizi, Sholeh, Muhammed Awad, Mahnaz Ramezanpour, Clare Cooksley, William Murphy, Clive A. Prestidge, Alkis J. Psaltis, Peter-John Wormald, Simone Barry, and Sarah Vreugde. 2024. “Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium Abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.” ACS Applied Materials & Interfaces 16 (51): 70274–83. doi:10.1021/acsami.4c15843.